MPM BIOIMPACT LLC

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1687078 BOSTON, MA

Position in EWTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$65,852,291

+$13,540,367 QoQ

Shares Held

1,620,780

-2.4% QoQ

Ownership

1.49%

of shares outstanding

% of Portfolio

4.02%

of 13F equity value

Holder Rank

#20

of 223 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MPM BIOIMPACT LLC holds $1,463,416,616 across 34 Biotechnology names. EWTX ranks #5 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CGEM	Cullinan Therapeutics, Inc.	9,731,341	$177,207,719
2	AKTS	Aktis Oncology, Inc.	4,835,872	$155,860,154
3	RVMD	Revolution Medicines, Inc.	492,483	$92,232,216
4	CORT	Corcept Therapeutics Inc	771,028	$67,040,884
5	EWTX	Edgewise Therapeutics, Inc. This page	1,620,780	$65,852,291
6	TVTX	Travere Therapeutics, Inc.	1,122,731	$63,782,348
7	DBVT	DBV Technologies S.A.	3,666,284	$60,127,057
8	TRVI	Trevi Therapeutics, Inc.	3,073,577	$57,322,211

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$65,852,291	1,620,780	-2.4%	Shares	Sole	2026-08-14
2026-03-31	$52,311,924	1,660,696	+0.3%	Shares	Sole	2026-05-15
2025-12-31	$41,075,177	1,655,256	-3.8%	Shares	Sole	2026-02-17
2025-09-30	$27,910,419	1,720,741	0.0%	Shares	Sole	2025-11-14
2025-06-30	$22,558,914	1,720,741	+55.7%	Shares	Sole	2025-08-14
2025-03-31	$24,319,768	1,105,444	+2.4%	Shares	Sole	2025-05-15
2024-12-31	$28,817,737	1,079,316	+17.7%	Shares	Sole	2025-02-14
2024-09-30	$24,479,160	917,166	+23.8%	Shares	Sole	2024-11-13
2024-06-30	$13,339,304	740,661	+67.9%	Shares	Sole	2024-08-14
2024-03-31	$8,048,564	441,259	-38.1%	Shares	Sole	2024-05-15
2023-06-30	$5,524,184	712,798	+134.5%	Shares	Sole	2023-08-14
2022-09-30	$2,991,625	304,027	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.